BioPharmaDispatch Executive

CEO and managing director Dr Paul McKenzie said, “CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in our core Ig franchise. We continue to advance key initiatives to improve gross margin, which is tracking according to our plans."

“We are extremely excited about the new journey we are undertaking in Thailand,” said Specialised Therapeutics CEO Carlo Montagner.

Rare Cancers Australia has released its 2025 Election Priorities, which advocate for consistent access to specialised expertise, treatments, and genomic medicines.

Josie Downey, the managing director of Merck Healthcare Australia and New Zealand, has welcomed Jo Galea to the company's leadership team.

Sandoz hosted a summit in Canberra this week to promote reforms aimed at increasing the use of biosimilar. Biosimilar policy has stagnated in recent years with no meaningful focus on reform. In...

Australian clinical-stage radiopharmaceutical company AdvanCell has announced an expansion of its strategic collaboration with Eli Lilly to research and develop innovative cancer treatments.

CEO and managing director Dr Paul McKenzie said, “CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in our core Ig franchise. We continue to advance key initiatives to improve gross margin, which is tracking according to our plans."

Not-for-profit genomics company Omico is launching a new podcast, Cancer Meets its Match, designed to assist people diagnosed with difficult cancers, along with their families and carers.

Stakeholders arguing for meaningful reform in other parts of the PBS should take heart. The adoption of pharmacy prescribing shows that the system can compromise on longstanding articles of faith when the case for change is effectively made.

PSA national president Associate Professor Fei Sim said, "This announcement will take these programs one step further, allowing pharmacists to initiate hormonal contraceptives and supply medications under the PBS for the first time."

Allowing pharmacies to prescribe and dispense PBS-subsidised medicines is undeniably one of the most significant reforms in the program's eight-decade history.

“It is enormously encouraging to see a key recommendation from the Senate inquiry into menopause being put into action, with these modern menopausal hormone therapies becoming readily accessible for all Australian women,” said Geoff Blundell, the managing director of Besins Healthcare Australia.